Literature DB >> 26021932

Complete Genome Sequence of Uropathogenic Escherichia coli Strain CI5.

Kurosh S Mehershahi1, Soman N Abraham, Swaine L Chen2.   

Abstract

Escherichia coli represents the primary etiological agent responsible for urinary tract infections, one of the most common infections in humans. We report here the complete genome sequence of uropathogenic Escherichia coli strain CI5, a clinical pyelonephritis isolate used for studying pathogenesis.
Copyright © 2015 Mehershahi et al.

Entities:  

Year:  2015        PMID: 26021932      PMCID: PMC4447917          DOI: 10.1128/genomeA.00558-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Urinary tract infections (UTIs) are one of the most frequently encountered bacterial infections, with uropathogenic Escherichia coli (UPEC) responsible for more than 80% of community acquired infections (1). Although often characterized as self-limiting and amenable to antibiotic therapy, UTIs often recur, causing significant morbidity to individual patients (2). Recurrent UTIs further lead to potential public health concerns due to high antibiotic usage (3, 4). Studies of UPEC pathogenesis have revealed that intracellular infection of bladder epithelial cells is a key feature leading to bacterial survival, antibiotic resistance, and recurrent UTI (5–20). UPEC strain CI5 is a clinical pyelonephritis isolate (21) that has been used in many of these studies using both in vitro cell culture models and in vivo murine infection models (22, 23). These have examined the role of Toll-like receptor 4 (TLR4) (13), cyclic AMP (cAMP), and Ca2+ signaling during UPEC invasion into bladder epithelial cells and the subsequent epithelial cell response (12, 16, 24). Additional studies have used CI5 to understand kidney infection and renal nephropathy during in vivo infection in mice (25). The genome sequence of CI5 will thus serve as a useful resource for future studies into the infection cycle of this important human pathogen. CI5 genomic DNA was sheared to a size of approximately 10 kbp using a g-Tube (Covaris). An SMRTbell library was prepared according to the manufacturer’s instructions, loaded with a MagBead bound library protocol, and sequenced using the P4-C2 chemistry on the PacBio RS II instrument (Pacific Biosciences) with a 180-min movie time. De novo assembly was performed with the Hierarchical Genome Assembly Process (HGAP3) in the SMRT Analysis suite version 2.3 using default parameters (26). In total, there were 249,158 reads and 822,531,331 nucleotides that passed filtering, representing an approximate coverage of 80× (based on the final assembly) and a preassembly mean read length of 8,815 bp. UPEC CI5 harbors a single chromosome of 4,885,378 bp with a G+C content of 50.8% and a previously unknown plasmid (pCI5) of 207,265 bp with a G+C content of 47.3%. Annotations of the CI5 genome and plasmid were performed using the NCBI Prokaryotic Genome Annotation Pipeline (PGAAP) (27). The CI5 chromosome and plasmid together contain 4,879 protein coding sequences, as well as 22 rRNA and 88 tRNA genes. The finished genome sequence of UPEC CI5 and its newly discovered plasmid pCI5 will aid in precise genetic manipulation and thereby further improve the study of UPEC virulence.

Nucleotide accession numbers.

The complete sequences of the uropathogenic E. coli CI5 chromosome and plasmid have been submitted to GenBank under the accession numbers CP011018 and CP011019, respectively.
  27 in total

1.  Uropathogenic Escherichia coli invades host cells via an HDAC6-modulated microtubule-dependent pathway.

Authors:  Bijaya K Dhakal; Matthew A Mulvey
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

2.  Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli.

Authors:  M A Mulvey; Y S Lopez-Boado; C L Wilson; R Roth; W C Parks; J Heuser; S J Hultgren
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

3.  Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data.

Authors:  Chen-Shan Chin; David H Alexander; Patrick Marks; Aaron A Klammer; James Drake; Cheryl Heiner; Alicia Clum; Alex Copeland; John Huddleston; Evan E Eichler; Stephen W Turner; Jonas Korlach
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

4.  Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.

Authors:  J J Martinez; M A Mulvey; J D Schilling; J S Pinkner; S J Hultgren
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

5.  Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.

Authors:  Drew J Schwartz; Swaine L Chen; Scott J Hultgren; Patrick C Seed
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

Review 6.  The epidemiology of urinary tract infection.

Authors:  Betsy Foxman
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

Review 7.  Epidemiology of urinary tract infections: incidence, morbidity, and economic costs.

Authors:  Betsy Foxman
Journal:  Am J Med       Date:  2002-07-08       Impact factor: 4.965

Review 8.  Urinary tract infections: current and emerging management strategies.

Authors:  Amelia E Barber; J Paul Norton; Adam M Spivak; Matthew A Mulvey
Journal:  Clin Infect Dis       Date:  2013-05-03       Impact factor: 9.079

9.  A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells.

Authors:  Jeongmin Song; Matthew J Duncan; Guojie Li; Cheryl Chan; Richard Grady; Ann Stapleton; Soman N Abraham
Journal:  PLoS Pathog       Date:  2007-04       Impact factor: 6.823

10.  Interplay between vesicoureteric reflux and kidney infection in the development of reflux nephropathy in mice.

Authors:  Samantha E Bowen; Christine L Watt; Inga J Murawski; Indra R Gupta; Soman N Abraham
Journal:  Dis Model Mech       Date:  2013-03-15       Impact factor: 5.758

View more
  3 in total

1.  Loss of Bladder Epithelium Induced by Cytolytic Mast Cell Granules.

Authors:  Hae Woong Choi; Samantha E Bowen; Yuxuan Miao; Cheryl Y Chan; Edward A Miao; Magnus Abrink; Adam J Moeser; Soman N Abraham
Journal:  Immunity       Date:  2016-12-06       Impact factor: 31.745

2.  Comparative Pathogenomics of Escherichia coli: Polyvalent Vaccine Target Identification through Virulome Analysis.

Authors:  J R Clark; A M Maresso
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

3.  Intracellular Uropathogenic E. coli Exploits Host Rab35 for Iron Acquisition and Survival within Urinary Bladder Cells.

Authors:  Neha Dikshit; Pradeep Bist; Shannon N Fenlon; Niyas Kudukkil Pulloor; Christelle En Lin Chua; Marci A Scidmore; Jason A Carlyon; Bor Luen Tang; Swaine L Chen; Bindu Sukumaran
Journal:  PLoS Pathog       Date:  2015-08-06       Impact factor: 7.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.